A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. Objective: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Scriba, Thomas J., Tameris, Michele, Smit, Erica, van der Merwe, Linda, Hughes, E. Jane, Kadira, Blessing, Mauff, Katya, Moyo, Sizulu, Brittain, Nathaniel, Lawrie, Alison, Mulenga, Humphrey, de Kock, Marwou, Makhethe, Lebohang, Janse van Rensburg, Esme, Gelderbloem, Sebastian, Veldsman, Ashley, Hatherill, Mark, Geldenhuys, Hendrik, Hill, Adrian V. S., Hawkridge, Anthony, Hussey, Gregory D., Hanekom, Willem A., McShane, Helen, Mahomed, Hassan
Format: Artigo
Jezik:Inglês
Izdano: American Thoracic Society 2012
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326425/
https://ncbi.nlm.nih.gov/pubmed/22281831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1548OC
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki